Date published: 2025-10-25

1-800-457-3801

SCBT Portrait Logo
Seach Input

Olfr944 Inhibitors

Olfr944, a member of the olfactory receptor family 8 subfamily G, is a G-protein-coupled receptor (GPCR) integral to the olfactory system in Mus musculus. These receptors are key to the detection and transduction of odorant signals, leading to the perception of smell. Structurally, Olfr944 shares the common GPCR architecture of a 7-transmembrane domain, a characteristic feature that enables the receptor to interact with specific odorant molecules. Upon binding with these molecules, Olfr944 initiates a signal transduction cascade via G-protein activation, leading to a neuronal response. This intricate process is a hallmark of the olfactory system's ability to detect and differentiate a wide range of olfactory stimuli, making olfactory receptors like Olfr944 crucial for the sense of smell.

Inhibiting Olfr944 involves either direct interference with its ligand-binding domain or indirect modulation of its signaling pathways or cellular environment. Direct inhibition would entail blocking the interaction between Olfr944 and its odorant ligands, thereby preventing the initiation of the G-protein-mediated signal transduction. This method requires a high degree of specificity to ensure targeted inhibition without affecting other GPCRs. Indirect inhibition, on the other hand, encompasses a broader approach, including altering the membrane dynamics or receptor conformation, which can influence the receptor's ability to interact with ligands or activate G-proteins. Additionally, targeting the downstream signaling pathways or the regulatory mechanisms of the receptor can modulate its activity. For instance, influencing the intracellular pathways that regulate receptor desensitization, internalization, or recycling can significantly impact the receptor's signaling efficiency. The chemical inhibitors listed in the table above represent potential indirect inhibitors of Olfr944, each acting through different mechanisms, ranging from cytochrome P450 enzyme inhibition to modulation of neurotransmitter receptors and alteration of G-protein coupling. Understanding the mechanisms underlying the function and inhibition of Olfr944 offers valuable insights into the broader context of GPCR-mediated signal transduction. The specific and diverse nature of olfactory receptors, including Olfr944, underlines the complexity of targeting these receptors for modulation.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Clotrimazole

23593-75-1sc-3583
sc-3583A
100 mg
1 g
$41.00
$56.00
6
(2)

Clotrimazole, an antifungal agent, inhibits cytochrome P450 enzymes, disrupting steroid biosynthesis. This interference may alter GPCR function, including olfactory receptors like Olfr944, by affecting membrane properties and receptor conformation.

(RS)-Atenolol

29122-68-7sc-204895
sc-204895A
1 g
10 g
$77.00
$408.00
1
(1)

Atenolol, a selective beta-1 adrenergic blocker, impacts GPCR-mediated signaling. It can lead to altered G-protein coupling efficiency in receptors like Olfr944, indirectly affecting their olfactory signal transduction.

Risperidone

106266-06-2sc-204881
sc-204881A
sc-204881B
sc-204881C
10 mg
50 mg
1 g
5 g
$171.00
$705.00
$1000.00
$2000.00
1
(1)

Risperidone, an atypical antipsychotic, acts on various neurotransmitter receptors, including GPCRs. Its broad receptor interaction profile can lead to modulation of GPCR pathways, indirectly affecting Olfr944 activity in olfaction.

Bisoprolol

66722-44-9sc-278792
25 mg
$204.00
(0)

Bisoprolol, a selective beta-1 adrenergic receptor blocker, affects GPCR signaling indirectly. By blocking beta-1 receptors, it can alter G-protein coupling in related GPCRs, potentially impacting Olfr944 function.

Ranitidine

66357-35-5sc-203679
1 g
$189.00
(1)

Ranitidine, a histamine H2 receptor antagonist, can indirectly modulate GPCR activity. By inhibiting H2 receptors, it affects histamine-mediated modulation of GPCRs, potentially influencing Olfr944 signaling.

Carvedilol

72956-09-3sc-200157
sc-200157A
sc-200157B
sc-200157C
sc-200157D
100 mg
1 g
10 g
25 g
100 g
$122.00
$235.00
$520.00
$979.00
$1500.00
2
(1)

Carvedilol, a non-selective beta and alpha-1 adrenergic blocker, affects GPCR signaling indirectly. By blocking these receptors, it can alter G-protein coupling in related GPCRs, potentially impacting Olfr944 function.

Sotalol hydrochloride

959-24-0sc-203699
sc-203699A
10 mg
50 mg
$67.00
$246.00
3
(1)

Sotalol, an antiarrhythmic agent, can influence GPCR function due to its beta-blocker properties. This can lead to indirect modulation of GPCR signaling pathways, potentially affecting Olfr944.